Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which steroid helps kids wake up faster after surgery?

NCT ID NCT07175623

Knowledge-focused Sponsor: Konya City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how two common steroids, methylprednisolone and dexamethasone, affect the time it takes for children to recover from muscle relaxants used during surgery. Sixty children aged 5 to 12 received one of the steroids or a placebo before their operation. The goal was to see which steroid helps reverse the muscle relaxant fastest and reduces pain and nausea afterward.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
methylprednisolone and dexamethasone (steroids)
What this could lead to
If successful, this could help anesthesiologists choose the best steroid to speed recovery from muscle relaxants in children, reducing side effects like pain and nausea.
What could go wrong
This is a small, completed trial with only 60 children. Results may not apply to all ages or surgeries, and the exact impact on recovery time is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 5-12 years * American Society of Anesthesiologists (ASA) physical status I-II Exclusion Criteria: * ASA physical status ≥ III * Emergency surgery * Known allergy or contraindication to neuromuscular blocking agents, sugammadex, or corticosteroids * Chronic or recent systemic corticosteroid use (within the last 3 months) * Neuromuscular disorders (e.g., muscular dystrophy, myasthenia gravis) * Severe hepatic or renal dysfunction * Significant respiratory or cardiac disease * Anticipated difficult airway or history of difficult intubation * Developmental delay or craniofacial anomalies affecting airway management * Refusal of consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuromuscular block, residual are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia Delayed Emergence from Anesthesia Pain, Postoperative Postoperative Nausea and Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuromuscular block, residual Pain management Postoperative nausea

Contacts and locations

Locations

  • Bezmialem Vakıf Univerisity Dragos Hospital

    Istanbul, Turkey (Türkiye)

  • Konya City Hospital

    Konya, Karatay, 42050, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.